Antiangiogenic potential of 10-hydroxycamptothecin.
Antiangiogenic potential of 10-hydroxycamptothecin.
复制标题
DOI:
10.1016/s0024-3205(01)01236-x
复制
发表时间:
2001-08
期刊:
影响因子:
6.1
通讯作者:
Dong Xiao;W. Tan;M. Li;Jian Ding
中科院分区:
文献类型:
--
作者:
Dong Xiao;W. Tan;M. Li;Jian Ding
To investigate the antiangiogenic potential of 10-hydroxycamptothecin (HCPT), the proliferation of human microvascular endothelial cells (HMEC) and seven human tumor cell lines were detected by SRB assay, and the endothelial cell migration and tube formation were assessed using two in vitro model systems. Also, inhibition of angiogenesis was determined with a modification of the chick embryo chorioallantoic membrane (CAM) assay in vivo. Morphological assessment of apoptosis was performed by fluorescence microscope. HCPT 0.313–5 μmol.L−1treatment resulted in a dose-dependent inhibition of proliferation, migration and tube formation in HMEC cells, and HCPT 6.25–25 nmol.egg−1inhibited angiogenesis in CAM assay. HCPT 1.25–5 μmol.L−1elicited typical morphological changes of apoptosis including condensed chromatin, nuclear fragmentation, and reduction in volume in HMEC cells. HCPT significantly inhibited angiogenesis both in vitro and in vivo at relatively low concentrations, and this effect was related with induction of apoptosis in HMEC cells. These results taken collectively suggest that HCPT may be a potent antiangiogenetic and cytotoxic drug and further investigation is warranted.